CARRIE LYNN BYINGTON, MD
Medical Practice at Mario Capecchi Dr, Salt Lake City, UT
License number
Utah 295001-1205
Category
Medical Practice
Type
Pediatric Infectious Diseases
Address
Address
100 Mario Capecchi Dr, Salt Lake City, UT 84113
Phone
(801) 587-9244
(801) 213-3900
(801) 213-3900
Personal information
See more information about CARRIE LYNN BYINGTON at radaris.comName
Address
Phone
924 E 200 S, Salt Lake City, UT 84102
1733 Harvard Ave, Salt Lake City, UT 84108
7720 Highway 89, Willard, UT 84340
Professional information
See more information about CARRIE LYNN BYINGTON at trustoria.com
Professor Of Pediatrics At University Of Utah
Professor Of Pediatrics At University Of Utah
Position:
Professor of Pediatrics at University of Utah
Location:
Greater Salt Lake City Area
Industry:
Medical Practice
Work:
University of Utah
-
Professor of Pediatrics
Dr. Carrie L Byington, Salt Lake City UT - MD (Doctor of Medicine)
Dr. Carrie L Byington, Salt Lake City UT - MD (Doctor of Medicine)
Specialties:
Pediatric Infectious Disease Medicine
Address:
South Main Clinic
3690 S Main St, Salt Lake City 84115
(385) 468-4000 (Phone)
3690 S Main St, Salt Lake City 84115
(385) 468-4000 (Phone)
Certifications:
Pediatric Infectious Disease Medicine, 2005, Pediatrics, 2000
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
South Main Clinic
3690 S Main St, Salt Lake City 84115
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
3690 S Main St, Salt Lake City 84115
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
Education:
Medical School
Baylor University
Graduated: 1989
Baylor College Of Medicine
University Of California-San Francisco
Baylor University
Graduated: 1989
Baylor College Of Medicine
University Of California-San Francisco
Carrie Lynn Byington, Salt Lake City UT
Carrie Lynn Byington, Salt Lake City UT
Specialties:
General Practice, Pediatrics, Pediatric Infectious Diseases
Work:
Uuhc South Main Clinic
3690 S Main St, Salt Lake City, UT 84115 Univ. Of Utah/Hlth. Sci. Ctr/Path
50 N Medical Dr, Salt Lake City, UT 84132 Pediatric Infectious Diseases
100 Mario Capecchi Dr, Salt Lake City, UT 84113
3690 S Main St, Salt Lake City, UT 84115 Univ. Of Utah/Hlth. Sci. Ctr/Path
50 N Medical Dr, Salt Lake City, UT 84132 Pediatric Infectious Diseases
100 Mario Capecchi Dr, Salt Lake City, UT 84113
Education:
Baylor College of Medicine (1989)
Carrie Lynn Byington, Salt Lake City UT
Carrie Lynn Byington, Salt Lake City UT
Specialties:
Pediatrician
Address:
50 N Medical Dr, Salt Lake City, UT 84132
100 Mario Capecchi Dr, Salt Lake City, UT 84113
University Of Utah, Salt Lake City, UT 84132
100 Mario Capecchi Dr, Salt Lake City, UT 84113
University Of Utah, Salt Lake City, UT 84132
Education:
Baylor University, College of Medicine - Doctor of Medicine
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Pediatrics Sub-certificate in Pediatric Infectious Diseases (Pediatrics)
Method For Creating And Using A Treatment Protocol
Method For Creating And Using A Treatment Protocol
US Patent:
2006015, Jul 13, 2006
Filed:
Feb 7, 2003
Appl. No.:
10/503033
Inventors:
Carrie Byington - SALT LAKE CITY UT, US
Andrew Pavia - Salt Lake City UT, US
John Christenson - Carmel IN, US
Andrew Pavia - Salt Lake City UT, US
John Christenson - Carmel IN, US
International Classification:
G06N 5/02
US Classification:
706047000
Abstract:
Systems, devices, methods, and software are provided that are suitable for use in the creation, implementation, use and/or refinement of treatment protocols. The software is configured for use in a client-server environment where the server communicates with client devices such as PDAs, laptops, tablets, or desktop computers. The software is directed to programming for basing an assessment of risk of bacterial infection in a subject on the presence, or lack, of viral illness in that subject. The diagnosis of viral illness is made through the use of results obtained from an enterovirus polymerase chain reaction test or a direct fluorescent assay test for respiratory viruses. Such test data, in conjunction with ‘time to positivity’ data for urine, blood, cerebrospinal fluid, or other cultures, is then processed by the software to assess the individual risk of occurrence of various conditions, such as bacterial infection, in a particular subject.